arsenic has been researched along with Human T-lymphotropic Virus 1 Infection in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (16.67) | 18.2507 |
2000's | 1 (16.67) | 29.6817 |
2010's | 4 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bazarbachi, A; Berry, F; Dassouki, Z; de Thé, H; El Hajj, H; Ezzedine, M; Farid, R; Ghantous, A; Ghavamzadeh, A; Hermine, O; Kchour, G; Kooshyar, MM; Mahmoudi, M; Mortada, M; Nasser, R; Rafatpanah, H; Rahimi, H; Rezaee, R; Shirdel, A; Tarhini, M | 1 |
Abe, Y; Kamada, H; Minowa, K; Nabeshi, H; Nagano, K; Nomura, T; Shibata, H; Sugita, T; Tsunoda, S; Tsutsumi, Y; Yoshikawa, T | 1 |
Bazarbachi, A; Fields, P; Hermine, O; Suarez, F | 1 |
Bazarbachi, A; Contamin, H; de Thé, H; Gessain, A; Heraud, JM; Hermine, O; Kazanji, M; Mahieux, R; Merien, F; Mortreux, F; Pouliquen, JF; Wattel, E | 1 |
Arima, T; Chyuman, Y; Hanada, S; Ishitsuka, K; Makino, T; Shimotakahara, S; Suzuki, S; Takeshita, T; Takeuchi, S; Uozumi, K; Utsunomiya, A | 1 |
Gallo, RC | 1 |
1 review(s) available for arsenic and Human T-lymphotropic Virus 1 Infection
Article | Year |
---|---|
Research and discovery of the first human cancer virus, HTLV-1.
Topics: Adult; Animals; Antiviral Agents; Arsenic; Cell Proliferation; Cell Transformation, Viral; Host-Pathogen Interactions; HTLV-I Infections; Human T-lymphotropic virus 1; Humans; Interferons; Leukemia-Lymphoma, Adult T-Cell; Mice; Mice, Transgenic; Viral Proteins; Virus Replication; Zidovudine | 2011 |
5 other study(ies) available for arsenic and Human T-lymphotropic Virus 1 Infection
Article | Year |
---|---|
The combination of arsenic, interferon-alpha, and zidovudine restores an "immunocompetent-like" cytokine expression profile in patients with adult T-cell leukemia lymphoma.
Topics: Adult; Aged; Arsenic Trioxide; Arsenicals; Cytokines; Female; Gene Expression Profiling; HTLV-I Infections; Humans; Immunologic Factors; Interferon-alpha; Leukemia-Lymphoma, Adult T-Cell; Male; Middle Aged; Oxides; Prospective Studies; Treatment Outcome; Zidovudine | 2013 |
Arsenic trioxide induces down-regulation of gp46 via protein oxidation: proteomics analysis of oxidative modified proteins in As2O3-treated HTLV-1-infected cells.
Topics: Arsenic Trioxide; Arsenicals; Cell Fusion; Down-Regulation; Electrophoresis, Gel, Two-Dimensional; Endoplasmic Reticulum Chaperone BiP; Gels; Gene Products, env; HeLa Cells; HTLV-I Infections; Humans; Hydrolysis; Immunoprecipitation; Oxidation-Reduction; Oxides; Proteomics; Retroviridae Proteins, Oncogenic; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Trypsin | 2010 |
How I treat adult T-cell leukemia/lymphoma.
Topics: Anti-Retroviral Agents; Antibodies, Monoclonal; Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Hematopoietic Stem Cell Transplantation; HTLV-I Infections; Human T-lymphotropic virus 1; Humans; Leukemia-Lymphoma, Adult T-Cell; Oxides | 2011 |
The efficacy of combined therapy of arsenic trioxide and alpha interferon in human T-cell leukemia virus type-1-infected squirrel monkeys (Saimiri sciureus).
Topics: Animals; Antiviral Agents; Arsenic Trioxide; Arsenicals; Cell Line, Transformed; Drug Therapy, Combination; HTLV-I Infections; Human T-lymphotropic virus 1; Humans; Interferon-alpha; Male; Oxides; Saimiri; Treatment Outcome | 2006 |
Arsenic trioxide inhibits growth of human T-cell leukaemia virus type I infected T-cell lines more effectively than retinoic acids.
Topics: Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Cell Division; HTLV-I Infections; Human T-lymphotropic virus 1; Humans; Oxides; T-Lymphocytes; Tretinoin; Tumor Cells, Cultured | 1998 |